A B S T R A C T In long-term well adapted kidney transplant recipients we have found a close correlation between the T helper (TH):T suppressor/cytotoxic (Ts/c) subset ratios and the presence of T cells that respond in the autologous mixed lymphocyte reaction (AMLR). In 21 recipients with T cell E rosette levels ranging between 53 and 86% and TH:TS/c ratios between 0.15 to 2.10, ratios of >0.8 correlated with AMLR responses (13/13), and ratios of <0.8 with AMLR nonreactivity (7/7). By contrast, the allogeneic MLR showed no apparent correlation with the TH:Ts/c ratios or with the AMLR pre-or postoperatively. It was found that the AMLR in 22 of 23 normal individuals was markedly inhibited by autologous T cells obtained from peripheral blood lymphocytes, exposed to 3,000 rad (Tx) and added as a third component to the cultures. In contrast, 13 of 13 kidney transplant recipients failed to exhibit this Tx AMLR inhibitory cell population. The "naturally occurring" T inhibitory cells, fractionated by an affinity column chromatography procedure into x-irradiated TH and Ts/c subsets, inhibited the AMLR to the same extent as unseparated Tx cells. In cell interchange studies performed in four of five HLA identical donor-recipient pairs the Tx cells of the (normal) donor inhibited the recipient AMLR (immunosuppressed), but recipient Tx cells failed to inhibit the donor AMLR. Finally T cells, primed in AMLR and allogeneic MLR for 10 d were tested for AMLR or allogeneic MLR inhibitory activity. Allogeneic MLR primed x-irradiated cells, inhibited both the AMLR and allogeneic MLR while AMLR x-irradiated primed cells inhibited neither reaction. The Tx AMLR inhib-
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INTRODUCTION
The autologous mixed lymphocyte reaction (AMLR)' has been thought to reflect an autoregulatory mechanism of immunity (1, 2) . The AMLR is highly sensitive to effects that alter normal immune homeostasis such as physiologic doses of corticosteroids (3) and autoimmune disease states (4, 5) . The reaction appears to be activated by a stimulating population of non-T cells fractionated from peripheral blood lymphocytes (PBL) (1) with a comparably small subset of T helper cells playing a major role in the response (6) . Both primary and secondary responses with kinetics similar to, but with less magnitude than, the allogeneic MLR have been described (7) , and cytotoxic cells have also been generated (8) . Although the responding cells in the AMLR have been reported for the most part to be mutually exclusive of those responding in the allogeneic MLR (9) , the antigens that stimulate the AMLR may or may not have a relation to lymphocyte defined (LD) antigens (7, 10) . Because of exquisite sensitivity of the AMLR to alteration of immune status in the human subject we embarked on a study of the factors that affect the reaction following renal transplantation.
In the present report we describe changes in the AMLR occurring after renal transplantation that directly relate to the T helper (TH) to T suppressor/cytotoxic (Ts/(,) cell ratio found in PBL. We also describe the inhibitory effects of x-irradiated T cells (Tx), isolated from peripheral blood and added as a third component to the AMLR, in normal individuals and in patients with end-stage renal disease before immunosuppressive therapy. Attempts were made to further purify the Tx inhibitory cell of the AMLR and T11 and Ts/(-subsets by a cellular affinity column technique (11) . We also asked whether the Tx AMLR inhibitor cells that were isolated from putatively quiescent PBL could be differentiated from the primed T suppressor cells that were generated in allogeneic MLR as we have previously described (12) , or from primed cells derived from the AMLR itself. Finally, we looked for this AMLR inhibitory T cell in transplant recipients undergoing immunosuppressive therapy and in a patient with an "autoimmune" disease state, and compared the effects of interchanging cellular elements between several genotyped HLA identical donor-recipient sibling pairs as a control for the disease and immunosuppressed state.
METHODS
Patients. The study subjects were pairs of living related donors and their corresponding transplant recipients or recipients of cadaveric kidneys (members of a pair designated as "B" for recipient and "D" for donor). Other subjects were "normal" unrelated volunteer blood donors, designated as "I", chosen to be two HLA DR antigen mismatches with R. The immunosuppressive therapy for the renal transplant recipients consisted of (1) azathioprine or cyclophosphamide and methylprednisolone (Medrol, Upjohn Co., Kalamazoo, MI) as a long-term regimen, with antilymphocyte globulin administered intravenously for 2 wk after transplantation, or (2) cyclosporin A and Medrol as long-term therapy in selected patients. The AMLR assays were performed on "normal" laboratory volunteers, on patients treated for end stage renal disease by hemodialysis before transplantation and on transplant recipients. Some of the study subjects were tested while being treated with immunosuppression before transplantation because of their original disease.
Cell preparation. Peripheral blood mononuclear cells were collected from whole blood using Ficoll-Hypaque density gradients. The Generation of primed T cells. In a procedure similar to one we have previously described (15) macrocultures of 1.2 X 10' responding cells and 0.6 X 106 stimulating cells of the allogeneic MLR (A + Ix) or the same number of T-cells stimulated with autologous NT cells in the AMLR, (T + NTx), were prepared in 2.0 ml vol of RPMI 1640 supplemented with L-glutamine, amphicillin, and 7% heat-inactivated fresh human serum and incubated for 9 d in a humidified atmosphere of 7% CO2. Several macrocultures were then aseptically pooled, washed three times with fresh unsupplemented medium, and the viability was determined. These primed cells were designated as A'I or T'NT. As an additional step the A'I cells were adjusted to 5 X 106/ml in RPMI 1640 supplemented with 20% FCS and mixed with an equal volume of 1% sheep erythrocytes that had been treated with aminoethylthioronium bromide (16) to isolate ERFC T cells as described above. This procedure enriched the A'I cells to >90% T cells (A'IT). The T'NT population was already shown to be maximally enriched to >90% T cells at 9 d in culture. The two cell populations A'IT and T'NT were adjusted to a concentration of 1 X 106/ml for use in the suppressor cell assay similar to one we have previously described (12) .
Suppressor cell assay. Cultures for both the allogeneic MLR and AMLR were prepared in microtiter plates containing 1 X 105 each of responder and x-irradiated stimulator cells in 0. 
RESULTS
Correlation between AMLR and T-helper:T-suppressor/cytotoxic ratio in kidney transplant recipients. Over 60 patients have been sequentially followed between 6 mo and 3 yr postoperatively, in the absence of rejection episodes and with normal renal function after transplantation, by serial monitoring of T cell subsets using anti-TH and Ts/c monoclonal antibodies and immunofluorescent cell counting (17, 18) . We have found that changes to severe inversion of the TH:Ts/c ratios have been associated with a propensity towards opportunistic infections despite normal E rosette T cell counts of PBL (19) . We asked whether there was a relationship between the presence of depressed TH:Ts/c ratios in PBL and the presence or absence of the AMLR. In Table I studies in 21 transplant patients are shown. 4 of these were recipients of transplants from HLA identical living related donors, 11 were from haploidentical living related donors, and 6 were from cadaver donors. All but two exhibited "normal" ERFC levels. However, the ratios of TH:Ts/c ranged from 0.15 to 2.10. The normal mean TH:Ts/c ratios using PBL of 23 "normal" volunteers in this laboratory was 1.84±0.21. The mean counts per minute [3H]thymidine uptake of the AMLR (RT + RNTx), allogeneic MLR (RT + Ix), and of control cultures (RT + RTx) are shown. We have defined a positive AMLR as a response in which the 9-d peak [3H]thymidine uptake of the experimental T + NTx was at least 1,000 cpm, and greater than three times the value of the control T + Tx. Using this criterion 8/8 patients with TH:Ts/c ratios of <0.8 had a negative AMLR and 13/ 13 patients with TH:Ts/c ratios of >0.8 had a positive AMLR. This was despite a significant difference in the dose of immunosuppression used between the two groups that might have led to the expectation of the opposite result, i.e., the mean dosage of Medrol was 0.19±0.009 (SE) mg/kg in the nonreactor group vs. 0.29±0.009 (SE) mg/kg in AMLR responders (P < 0.01) (20) , reflecting the individual sensitivity to immunosuppression indicated by both the AMLR and T cell subset ratios. By contrast, in 20 of the 21 recipients (including 7 of 8 AMLR nonreactors) the allogeneic MLR was relatively normal and showed no apparent correlation with the T cell subset ratios. Seven of eight patients studied before transplantation on maintenance hemodialysis were AMLR reactors (data not shown). The magnitude of the response in general was somewhat decreased, and less than that in many § One patient in this group was treated with cyclophosphamide in place of azathioprine. 11 Although these tests were performed using the same blood sample as the AMLR and allogeneic MLR, there was a variance of <10% over at least three monthly intervals for each patient during the study. Also, the percent TuI:Ts(: do not equal the total E rosetting cells and occasionally are in excess of this number.
¶ Azathioprine dosage in one patient. The others in this group were treated with cyclosporin A. Fig. 2 is shown the effect of Tx cells on the autologous T + NTx reactions. The inhibition of the T + NTx was -90% after the addition of Tx cells (P < 0.01). This T cell AMLR inhibition was also active in 6/6 patients tested who were on chronic maintenance hemodialysis in the absence of immunosuppression. In contrast to this finding, when a similar Tx cell inhibitor of the AMLR was looked for in PBL of kidney transplant recipients no such AMLR inhibitory effect was found. This absence of AMLR inhibitory cells was consistent regardless of the TH:Ts/c ratio or of the magnitude of response seen in the AMLR in 13/13 transplant patients with a positive AMLR.
One exception, however, was seen in the negative AMLR group (patient G.W., vide infra).
Effect of isolation of TH1 and TS1C T cell subsets from the AMLR T cell inhibitor population. Since T cell inhibitory population was also independent of in vitro-derived TH and Ts/c phenotypes isolated from PBL of normal individuals. We therefore separated the E rosette-purified T cells into TH and Ts/c subsets by affinity column chromatography (Fig. 1) . The effect of these T cell subsets added as x-irradiated third components in the AMLR is shown in Fig. 3 AMLR. By exchanging the cells between subjects identical at the major histocompatibility complex, the effects of allogeneic stimulation or inhibition would be excluded. We studied four HLA identical donor-recipient pairs after transplantation. The results (recipients F.F., M.W., D.T., and G.W.) are presented in Table II . As seen in the previous experiment, the AMLR of the normal donor was inhibited by the addition of x-irradiated autologous T cells, i.e., the DT + DNTx + DTx reaction was inhibited by at least 50% when compared with the DT + DNTx +; DNTx reaction (P < 0.01). The recipient T cells (RTx) failed to suppress the donor AMLR in three combinations studied (F.F., M.W., and D.T.). This was seen when DT + DNTx + DTX reaction was compared with DT + DNTx + RTx reaction. In two recipients (M.W. and D.T.) the AMLR was strong enough to be conversely tested with the addition of DTx cells, and an inhibitory effect was seen (RTx + RNTx + DTx vs. RTx + RNx + RTx (P > 0.01). Recipient F.F. had a low AMLR reaction at the outset, and although DTx inhibition was thought to be present (RTx + RNTx + DTx vs. RTx + RNTx + RTx) it was not as easily assessed (668 vs. 1,076 cpm). Expressed as mean of triplicate cultures with <10% variance. 5-and 7-d cultures did not differ significantly from each other within the experimental groups of each pair except for trends becoming significant at day 9. I Greater than 50% inhibition was considered suppression. (P < 0.01). § This recipient two-component AMLR was nonresponsive. Therefore inhibition by DTX cells could not be assessed. study between the presence of an RTx inhibitor of the AMLR, which could be demonstrated using the HLA identical donor responding cells (DT + DNT + RTX), and the absence of the AMLR in the recipient; the latter was more consistently dependent on the low TH:Ts/c ratio (0.19 in this patient). This exceptional observation, in a marginally immunosuppressed transplant recipient of the presence of Tx AMLR inhibitor cells in the absence of an AMLR, fortuitously seen because of the HLA identical cell interchange, again points to the independence of the Tx inhibitor to the TH:Ts/c ratio in vivo as pointed out in the preceding experiment using column-purified T cell subsets in vitro.
As an additional study using this three component assay and cell interchange an HLA A, B, C, D/Dr identical sibling pair (pair 5, B.L., Table II ) was studied before transplantation. The potential recipient was a 15-yr-old white male with "pseudo-Goodpasture's disease", i.e., hematuria and interstitial pulmonary hemorrhage, recurring episodically as he developed renal failure with biopsy proven glomerulonephritis in the absence of antiglomerular basement membrane antibody. His serum was 99% cytotoxic against a panel of 35 diverse HLA specificities, probably secondary to multiple transfusions, but negative when tested against an HLA identical sibling. At several intervals in his pretransplant course he was demonstrated to have autoantibodies (IgG) to his own T and B cells. He was treated with cyclophosphamide and prednisone. In the absence of continous antigenic stimulation of an allograft we asked what the effects of immunosuppression and/or autoimmunity might be on the presence of AMLR inhibitory T-cells in this patient. When the prospective donor DTx cells were added to DT + DNTx a strong inhibitory effect was seen (Table  II) . This was in contrast to the absence of inhibition seen with the addition of RTx to DT + DNTx. Inhibition of the AMLR and allogeneic MLR by allogeneic vs. autologous primed T cells. We have previously demonstrated the in vitro generation of allogeneic MLR primed human T suppressor cells that, when x-irradiated, suppressed the allogeneic MLR both specifically and nonspecifically (12) . It has also been reported that two distinct cell populations appeared to be active in the AMLR and the allogeneic MLR (22) , and that the AMLR has been associated with the generation of suppressor cells (9) . We therefore asked whether T cells primed in the AMLR and then x-irradiated would suppress either the AMLR or the allogeneic MLR and we compared this effect with Tx cells that had been primed in the allogeneic MLR. In these studies alloreactive primed cells from subject "A", a normal laboratory volunteer, and autologous primed cells of the same subject were generated by mixing A + Ix cells or AT + NTx, respectively, for 9 d in culture. The A'I cell population produced at this time interval in the allogeneic MLR was purified by the E resetting procedure to yield AT cells T'NTx cells added as third components to the AMLR are shown in Fig. 4B . The autologous primed T cell (T'NTx) did not inhibit the AMLR (in contrast to the naturally occurring freshly prepared Tx from PBL described in the previous experiment [ Fig. 2]) . However, the A'ITx inhibitory effect was similar to Tx obtained from PBL in the ability to suppress the AMLR. Also in the converse experiment, when x-irradiated allo-and auto-primed cells were added as third components to the allogeneic MLR A'ITx caused suppression (as previously described [12, 17] ) but T'NTx did not (Fig. 4C ).
DISCUSSION
The AMLR in normal subjects has not been clearly equated to any well defined immunological function, although the concept of a regulatory role in immune homeostasis has been proposed (1, 2). There may still be the reservation that it is an in vitro artifact, since mixing autologous T and non-T cells at 1 X 106/ml in culture is quite different from the densities at which such cells occur in vivo in peripheral blood. Kozak et al. (6) performed limiting dilution analysis on the AMLR to estimate the number of autoreactive T cells. If calculations are made using those data, assuming that the ratio of stimulating to responding cells required in vitro is also needed in vivo, the AMLR would not be measurable in peripheral blood (and indeed is not). It has also been estimated that the level of corticosteroids in blood might well be sufficient to suppress the in vivo AMLR (3) . Therefore, the occurrence of a measurable AMLR in vivo would require a compartmentilization or anatomical juxtaposition in fixed lymphoid tissue of the cells involved. This is rather different from the allogeneic MLR that we and others have measured using lymphocytes extracted from the infiltrated allograft (23, 24) . Notwithstanding, if the assumption is made that there is a biologic function of the AMLR, then the AMLR itself should require regulatory controls. In our search for these, we attempted to generate auto-and alloprimed T suppressor cells. (Fig. 4A, B, C) . In previous reports (12, 17) we have shown that both specific and nonspecific primed T suppressor cells can be generated in allogeneic MLR. In the present study autoprimed T'NTx failed to suppress the AMLR and had no effect on the proliferative response of fresh T even at this dose. This patient had had a prolonged aspergillus infection that resolved after pulmonary lobectomy and amphotericin B treatment as well as virtual discontinuance of immunosuppression therapy for 4 mo.) Quite possibly a different membrane marker might be present on these Tx natural AMLR inhibitory cells such as the Fc-IgG receptor T gamma cell, which is suppressive in various systems and which demonstrates >90% ERFC with OKT4 and OKT8 markers in roughly equal distribution (26) (27) (28) .
It has been proposed that the AMLR has a potential autoregulatory function in vivo by generating suppressor cells (9, 10) . In the present study, the paradoxical absence of a "natural" AMLR inhibitory T cell in the peripheral blood of immunosuppressed patients adds credence to this hypothesis. Immunosuppression would teleologically suppress the inhibitor of the autoregulator, i.e. result in a net suppressive effect consistent with a network hypothesis (29) (30) (31) .
We have previously reported that immunologic monitoring of transplant recipients produced benefits in two areas; in the nonspecific assessment of altered generalized resistance to opportunistic infections (primarily a T cell dependent function) and in the demonstration of specific regulatory activity toward alloantigens of the graft (16, 32, 33) . We began a study of the AMLR in transplant recipients because as an in vitro assay it appeared to have exquisite sensitivity, albeit nonspecific, to factors that alter immunity. This was in contrast to our previous immunological monitoring studies in which immunosuppressive therapy given in moderate dosage had no major effect on either the allogeneic MLR, the blastogenic response, nonspecific T cell cytotoxicity or antibody-dependent cellmediated cytotoxicity reactions. By monitoring the TH:Ts/c subset ratios, however, we did find significant inversions (17, 18) when patients were highly susceptible to infection even when only minimal dosages of immunosuppressive therapy were administered. If a gradation in sensitivity of these in vitro assays to the effects of immunosuppression were to be proposed, since TH:Ts/c ratios and AMLR assays were not affected (i.e. normal) but the Tx AMLR inhibitor cell was no longer present in all but one (G.W.) of the transplant recipients studied, this latter cell would be a candidate to be the most sensitive to the effects of immunosuppressive therapy. Following in descending order, the AMLR on a level with TH:Ts/c ratios appears to be the next most sensitive assay to be affected. The allogeneic MLR and the generation of cytotoxic T cells in this reaction (not shown), although perhaps more dependent on genetic disparity as well, are less sensitive. The latter assays were in general present independent of the TH:Ts/c ratios, and only appear to be affected when the total T cell E rosette population is depleted by prolonged high doses of such therapy (16) .
